You have 7 free searches left this month | for more free features.

antigen presenting cells (APCs)

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune Thrombocytopenic Purpura Trial in Sohag (Genotyping of rs1883832C/T related single-nucleotide polymorphism)

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • Genotyping of rs1883832C/T related single-nucleotide polymorphism
  • Sohag, Egypt
    Sohag University hospitals
Oct 16, 2022

Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

Recruiting
  • Influenza A
  • Pandemic Influenza
  • H7HLAII
  • Oslo, Norway
    Oslo University Hospital
Sep 20, 2023

Immune Function and the Progression to T1D

Recruiting
  • Type 1 Diabetes
  • blood draw
  • Gainesville, Florida
    Kieran McGrail
Jun 12, 2023

Dermatomyositis Trial in Washington (Abatacept)

Completed
  • Dermatomyositis
  • Washington, District of Columbia
    2300 M Street, 9th floor. Medical Faculty Associates, The George
Apr 5, 2022

Immune Thrombocytopenia Trial in Sohag (Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR)

Not yet recruiting
  • Immune Thrombocytopenia
  • Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR
  • Sohag, Egypt
    Sohag University Hospital
Jul 19, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Santa Monica (Trabectedin, Ipilimumab, Nivolumab)

Recruiting
  • Advanced Soft Tissue Sarcoma
  • Metastatic Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Research Center
May 4, 2022

Nonsquamous Nonsmall Cell Tumor of Lung Trial in Taipei (BLEX 404)

Not yet recruiting
  • Nonsquamous Nonsmall Cell Neoplasm of Lung
  • BLEX 404
  • Taipei, Taiwan
    Taipei Veteran General Hospital
Feb 28, 2023

Advanced Pancreatic Carcinoma Trial in Shenzhen (CD276 CAR-T cells)

Recruiting
  • Advanced Pancreatic Carcinoma
  • CD276 CAR-T cells
  • Shenzhen, Guangdong, China
    Li Yu
Dec 2, 2021

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Breast Cancer Trial in Portland (biological, drug, radiation)

Recruiting
  • Breast Cancer
  • DPX-Survivac
  • +3 more
  • Portland, Oregon
    Providence Portland Medical Center
Oct 19, 2021

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia Trial in Bergamo (Blinatumomab Expanded T-cells (BET))

Active, not recruiting
  • Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia
  • Blinatumomab Expanded T-cells (BET)
  • Bergamo, Italy
    ASST - Papa Giovanni XXIII
Dec 22, 2021

Plane Wart Trial in Qina (C. albicans antigen, autologous PRP, saline)

Active, not recruiting
  • Plane Wart
  • C. albicans antigen
  • +2 more
  • Qinā, Egypt
    South Valley University
Dec 7, 2022

Malignant Melanoma Trial in Herlev (Cyclophosphamide, Fludarabine Phosphate, Multiple Antigen Specific Endogenously derived T

Recruiting
  • Malignant Melanoma
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
Sep 14, 2021

Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Ipilimumab, Nivolumab)

Unknown status
  • Limited Stage Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Bendigo, Australia
  • +60 more
Feb 5, 2021

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

Neuromyelitis Optica Trial in Bron, Strasbourg (Blood sampling)

Recruiting
  • Neuromyelitis Optica
  • Blood sampling
  • Bron, France
  • +1 more
Mar 29, 2022

Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)

Recruiting
  • Langerhans Cell Histiocytosis of Bone
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
Oct 15, 2023

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Antigen-specific T Cells in Antisynthetase Syndrome and

Not yet recruiting
  • Antisynthetase Syndrome
  • BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
  • Dijon, France
  • +5 more
Aug 2, 2023

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and

Not yet recruiting
  • Multiple Sclerosis
  • Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic plasmacytoid Dendritic Cells
  • (no location specified)
Oct 10, 2022

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Pamplona (Nasal Photodisinfection, Sham

Completed
  • COVID-19 Respiratory Infection
  • SARS-CoV-2 Acute Respiratory Disease
  • Nasal Photodisinfection
  • Sham Comparator: Control
  • Pamplona, Spain
    Clinica Universidad de Navarra
Aug 10, 2022

Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023